Moderna Inc reported $1.04B in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amgen AMGN:US USD 2.14B 826M
Arrowhead Research ARWR:US USD -72046000 116.41M
Biogen BIIB:US USD 1.13B 76.7M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bluebird Bio BLUE:US USD -76520000 23.62M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Gilead Sciences GILD:US USD 1.79B 645M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
IONIS PHARMACEUT IONS:US USD -46992000 58.14M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Sangamo Biosciences SGMO:US USD -53155000 9.98M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
United Therapeutics UTHR:US USD 239.3M 123.3M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M
YTE INCY:US USD 112.78M 48.66M